{"id":"NCT00435370","sponsor":"Baylor College of Medicine","briefTitle":"Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia","officialTitle":"Tropisetron With Risperidone for Schizophrenia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-11","primaryCompletion":"2011-02","completion":"2011-08","firstPosted":"2007-02-14","resultsPosted":"2014-09-08","lastUpdate":"2017-03-15"},"enrollment":179,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Smoking Cessation","Schizophrenia"],"interventions":[{"type":"DRUG","name":"Tropisetron","otherNames":["Navoban"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Risperidone","otherNames":["Risperdal, Ridal, Rispolept"]}],"arms":[{"label":"Tropisetron","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will determine the effectiveness of tropisetron plus risperidone in improving cognitive symptoms in Chinese people with schizophrenia.","primaryOutcome":{"measure":"Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Cognition Domains","timeFrame":"end of 12 wk treatment","effectByArm":[{"arm":"Tropisetron","deltaMin":96,"sd":16},{"arm":"Placebo","deltaMin":95,"sd":15}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.05"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":9},"locations":{"siteCount":2,"countries":["United States","China"]},"refs":{"pmids":["37402747","22952075"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":90},"commonTop":["Other Adverse Event"]}}